0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs of UDCA and t-UDCA Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-18H8151
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and China Drugs of UDCA and t UDCA Market Insights Forecast to 2027
BUY CHAPTERS

Global Drugs of UDCA and t-UDCA Market Research Report 2025

Code: QYRE-Auto-18H8151
Report
July 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drugs of UDCA and t-UDCA Market Size

The global market for Drugs of UDCA and t-UDCA was valued at US$ 2141 million in the year 2024 and is projected to reach a revised size of US$ 4909 million by 2031, growing at a CAGR of 12.8% during the forecast period.

Drugs of UDCA and t-UDCA Market

Drugs of UDCA and t-UDCA Market

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drugs of UDCA and t-UDCA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs of UDCA and t-UDCA.
The Drugs of UDCA and t-UDCA market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs of UDCA and t-UDCA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs of UDCA and t-UDCA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drugs of UDCA and t-UDCA Market Report

Report Metric Details
Report Name Drugs of UDCA and t-UDCA Market
Accounted market size in year US$ 2141 million
Forecasted market size in 2031 US$ 4909 million
CAGR 12.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • t-UDCA
  • UDCA
Segment by Application
  • Gallstone
  • Hepatopathy
  • Biliary Disease
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Viatris, Bruschettini, Impax, Shanghai Pharma, Grindeks
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drugs of UDCA and t-UDCA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drugs of UDCA and t-UDCA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Drugs of UDCA and t-UDCA Market growing?

Ans: The Drugs of UDCA and t-UDCA Market witnessing a CAGR of 12.8% during the forecast period 2025-2031.

What is the Drugs of UDCA and t-UDCA Market size in 2031?

Ans: The Drugs of UDCA and t-UDCA Market size in 2031 will be US$ 4909 million.

Who are the main players in the Drugs of UDCA and t-UDCA Market report?

Ans: The main players in the Drugs of UDCA and t-UDCA Market are Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Viatris, Bruschettini, Impax, Shanghai Pharma, Grindeks

What are the Application segmentation covered in the Drugs of UDCA and t-UDCA Market report?

Ans: The Applications covered in the Drugs of UDCA and t-UDCA Market report are Gallstone, Hepatopathy, Biliary Disease, Other

What are the Type segmentation covered in the Drugs of UDCA and t-UDCA Market report?

Ans: The Types covered in the Drugs of UDCA and t-UDCA Market report are t-UDCA, UDCA

Recommended Reports

Biliary and Liver Diseases

Pharmaceutical Ingredients

Autoimmune and Chronic Diseases

1 Drugs of UDCA and t-UDCA Market Overview
1.1 Product Definition
1.2 Drugs of UDCA and t-UDCA by Type
1.2.1 Global Drugs of UDCA and t-UDCA Market Value Comparison by Type (2024 VS 2031)
1.2.2 t-UDCA
1.2.3 UDCA
1.3 Drugs of UDCA and t-UDCA by Application
1.3.1 Global Drugs of UDCA and t-UDCA Market Value by Application (2024 VS 2031)
1.3.2 Gallstone
1.3.3 Hepatopathy
1.3.4 Biliary Disease
1.3.5 Other
1.4 Global Drugs of UDCA and t-UDCA Market Size Estimates and Forecasts
1.4.1 Global Drugs of UDCA and t-UDCA Revenue 2020-2031
1.4.2 Global Drugs of UDCA and t-UDCA Sales 2020-2031
1.4.3 Global Drugs of UDCA and t-UDCA Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drugs of UDCA and t-UDCA Market Competition by Manufacturers
2.1 Global Drugs of UDCA and t-UDCA Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drugs of UDCA and t-UDCA Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drugs of UDCA and t-UDCA Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drugs of UDCA and t-UDCA, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs of UDCA and t-UDCA, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs of UDCA and t-UDCA, Product Type & Application
2.7 Global Key Manufacturers of Drugs of UDCA and t-UDCA, Date of Enter into This Industry
2.8 Global Drugs of UDCA and t-UDCA Market Competitive Situation and Trends
2.8.1 Global Drugs of UDCA and t-UDCA Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drugs of UDCA and t-UDCA Players Market Share by Revenue
2.8.3 Global Drugs of UDCA and t-UDCA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs of UDCA and t-UDCA Market Scenario by Region
3.1 Global Drugs of UDCA and t-UDCA Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drugs of UDCA and t-UDCA Sales by Region: 2020-2031
3.2.1 Global Drugs of UDCA and t-UDCA Sales by Region: 2020-2025
3.2.2 Global Drugs of UDCA and t-UDCA Sales by Region: 2026-2031
3.3 Global Drugs of UDCA and t-UDCA Revenue by Region: 2020-2031
3.3.1 Global Drugs of UDCA and t-UDCA Revenue by Region: 2020-2025
3.3.2 Global Drugs of UDCA and t-UDCA Revenue by Region: 2026-2031
3.4 North America Drugs of UDCA and t-UDCA Market Facts & Figures by Country
3.4.1 North America Drugs of UDCA and t-UDCA Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drugs of UDCA and t-UDCA Sales by Country (2020-2031)
3.4.3 North America Drugs of UDCA and t-UDCA Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drugs of UDCA and t-UDCA Market Facts & Figures by Country
3.5.1 Europe Drugs of UDCA and t-UDCA Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drugs of UDCA and t-UDCA Sales by Country (2020-2031)
3.5.3 Europe Drugs of UDCA and t-UDCA Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs of UDCA and t-UDCA Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs of UDCA and t-UDCA Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drugs of UDCA and t-UDCA Sales by Region (2020-2031)
3.6.3 Asia Pacific Drugs of UDCA and t-UDCA Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drugs of UDCA and t-UDCA Market Facts & Figures by Country
3.7.1 Latin America Drugs of UDCA and t-UDCA Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drugs of UDCA and t-UDCA Sales by Country (2020-2031)
3.7.3 Latin America Drugs of UDCA and t-UDCA Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs of UDCA and t-UDCA Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs of UDCA and t-UDCA Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drugs of UDCA and t-UDCA Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs of UDCA and t-UDCA Sales by Type (2020-2031)
4.1.1 Global Drugs of UDCA and t-UDCA Sales by Type (2020-2025)
4.1.2 Global Drugs of UDCA and t-UDCA Sales by Type (2026-2031)
4.1.3 Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2020-2031)
4.2 Global Drugs of UDCA and t-UDCA Revenue by Type (2020-2031)
4.2.1 Global Drugs of UDCA and t-UDCA Revenue by Type (2020-2025)
4.2.2 Global Drugs of UDCA and t-UDCA Revenue by Type (2026-2031)
4.2.3 Global Drugs of UDCA and t-UDCA Revenue Market Share by Type (2020-2031)
4.3 Global Drugs of UDCA and t-UDCA Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drugs of UDCA and t-UDCA Sales by Application (2020-2031)
5.1.1 Global Drugs of UDCA and t-UDCA Sales by Application (2020-2025)
5.1.2 Global Drugs of UDCA and t-UDCA Sales by Application (2026-2031)
5.1.3 Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2020-2031)
5.2 Global Drugs of UDCA and t-UDCA Revenue by Application (2020-2031)
5.2.1 Global Drugs of UDCA and t-UDCA Revenue by Application (2020-2025)
5.2.2 Global Drugs of UDCA and t-UDCA Revenue by Application (2026-2031)
5.2.3 Global Drugs of UDCA and t-UDCA Revenue Market Share by Application (2020-2031)
5.3 Global Drugs of UDCA and t-UDCA Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dr. Falk Pharma
6.1.1 Dr. Falk Pharma Company Information
6.1.2 Dr. Falk Pharma Description and Business Overview
6.1.3 Dr. Falk Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dr. Falk Pharma Drugs of UDCA and t-UDCA Product Portfolio
6.1.5 Dr. Falk Pharma Recent Developments/Updates
6.2 Daewoong Pharmaceutical
6.2.1 Daewoong Pharmaceutical Company Information
6.2.2 Daewoong Pharmaceutical Description and Business Overview
6.2.3 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product Portfolio
6.2.5 Daewoong Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Drugs of UDCA and t-UDCA Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Epic Pharma
6.4.1 Epic Pharma Company Information
6.4.2 Epic Pharma Description and Business Overview
6.4.3 Epic Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Epic Pharma Drugs of UDCA and t-UDCA Product Portfolio
6.4.5 Epic Pharma Recent Developments/Updates
6.5 Mitsubishi Tanabe Pharma
6.5.1 Mitsubishi Tanabe Pharma Company Information
6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.5.3 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product Portfolio
6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Company Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lannett Drugs of UDCA and t-UDCA Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 Viatris
6.7.1 Viatris Company Information
6.7.2 Viatris Description and Business Overview
6.7.3 Viatris Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Viatris Drugs of UDCA and t-UDCA Product Portfolio
6.7.5 Viatris Recent Developments/Updates
6.8 Bruschettini
6.8.1 Bruschettini Company Information
6.8.2 Bruschettini Description and Business Overview
6.8.3 Bruschettini Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bruschettini Drugs of UDCA and t-UDCA Product Portfolio
6.8.5 Bruschettini Recent Developments/Updates
6.9 Impax
6.9.1 Impax Company Information
6.9.2 Impax Description and Business Overview
6.9.3 Impax Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Impax Drugs of UDCA and t-UDCA Product Portfolio
6.9.5 Impax Recent Developments/Updates
6.10 Shanghai Pharma
6.10.1 Shanghai Pharma Company Information
6.10.2 Shanghai Pharma Description and Business Overview
6.10.3 Shanghai Pharma Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai Pharma Drugs of UDCA and t-UDCA Product Portfolio
6.10.5 Shanghai Pharma Recent Developments/Updates
6.11 Grindeks
6.11.1 Grindeks Company Information
6.11.2 Grindeks Description and Business Overview
6.11.3 Grindeks Drugs of UDCA and t-UDCA Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Grindeks Drugs of UDCA and t-UDCA Product Portfolio
6.11.5 Grindeks Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs of UDCA and t-UDCA Industry Chain Analysis
7.2 Drugs of UDCA and t-UDCA Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs of UDCA and t-UDCA Production Mode & Process Analysis
7.4 Drugs of UDCA and t-UDCA Sales and Marketing
7.4.1 Drugs of UDCA and t-UDCA Sales Channels
7.4.2 Drugs of UDCA and t-UDCA Distributors
7.5 Drugs of UDCA and t-UDCA Customer Analysis
8 Drugs of UDCA and t-UDCA Market Dynamics
8.1 Drugs of UDCA and t-UDCA Industry Trends
8.2 Drugs of UDCA and t-UDCA Market Drivers
8.3 Drugs of UDCA and t-UDCA Market Challenges
8.4 Drugs of UDCA and t-UDCA Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drugs of UDCA and t-UDCA Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drugs of UDCA and t-UDCA Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drugs of UDCA and t-UDCA Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drugs of UDCA and t-UDCA Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drugs of UDCA and t-UDCA Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drugs of UDCA and t-UDCA Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drugs of UDCA and t-UDCA Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drugs of UDCA and t-UDCA Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drugs of UDCA and t-UDCA, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drugs of UDCA and t-UDCA, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drugs of UDCA and t-UDCA, Product Type & Application
 Table 12. Global Key Manufacturers of Drugs of UDCA and t-UDCA, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drugs of UDCA and t-UDCA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of UDCA and t-UDCA as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drugs of UDCA and t-UDCA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drugs of UDCA and t-UDCA Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2020-2025)
 Table 19. Global Drugs of UDCA and t-UDCA Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drugs of UDCA and t-UDCA Sales Market Share by Region (2026-2031)
 Table 21. Global Drugs of UDCA and t-UDCA Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region (2020-2025)
 Table 23. Global Drugs of UDCA and t-UDCA Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drugs of UDCA and t-UDCA Revenue Market Share by Region (2026-2031)
 Table 25. North America Drugs of UDCA and t-UDCA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drugs of UDCA and t-UDCA Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drugs of UDCA and t-UDCA Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drugs of UDCA and t-UDCA Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drugs of UDCA and t-UDCA Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drugs of UDCA and t-UDCA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drugs of UDCA and t-UDCA Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drugs of UDCA and t-UDCA Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drugs of UDCA and t-UDCA Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drugs of UDCA and t-UDCA Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drugs of UDCA and t-UDCA Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drugs of UDCA and t-UDCA Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drugs of UDCA and t-UDCA Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drugs of UDCA and t-UDCA Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drugs of UDCA and t-UDCA Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drugs of UDCA and t-UDCA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drugs of UDCA and t-UDCA Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drugs of UDCA and t-UDCA Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drugs of UDCA and t-UDCA Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drugs of UDCA and t-UDCA Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drugs of UDCA and t-UDCA Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drugs of UDCA and t-UDCA Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drugs of UDCA and t-UDCA Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drugs of UDCA and t-UDCA Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drugs of UDCA and t-UDCA Sales (K Units) by Type (2020-2025)
 Table 51. Global Drugs of UDCA and t-UDCA Sales (K Units) by Type (2026-2031)
 Table 52. Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2020-2025)
 Table 53. Global Drugs of UDCA and t-UDCA Sales Market Share by Type (2026-2031)
 Table 54. Global Drugs of UDCA and t-UDCA Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drugs of UDCA and t-UDCA Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drugs of UDCA and t-UDCA Revenue Market Share by Type (2020-2025)
 Table 57. Global Drugs of UDCA and t-UDCA Revenue Market Share by Type (2026-2031)
 Table 58. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drugs of UDCA and t-UDCA Sales (K Units) by Application (2020-2025)
 Table 61. Global Drugs of UDCA and t-UDCA Sales (K Units) by Application (2026-2031)
 Table 62. Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2020-2025)
 Table 63. Global Drugs of UDCA and t-UDCA Sales Market Share by Application (2026-2031)
 Table 64. Global Drugs of UDCA and t-UDCA Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drugs of UDCA and t-UDCA Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drugs of UDCA and t-UDCA Revenue Market Share by Application (2020-2025)
 Table 67. Global Drugs of UDCA and t-UDCA Revenue Market Share by Application (2026-2031)
 Table 68. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Application (2026-2031)
 Table 70. Dr. Falk Pharma Company Information
 Table 71. Dr. Falk Pharma Description and Business Overview
 Table 72. Dr. Falk Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Dr. Falk Pharma Drugs of UDCA and t-UDCA Product
 Table 74. Dr. Falk Pharma Recent Developments/Updates
 Table 75. Daewoong Pharmaceutical Company Information
 Table 76. Daewoong Pharmaceutical Description and Business Overview
 Table 77. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product
 Table 79. Daewoong Pharmaceutical Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teva Drugs of UDCA and t-UDCA Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Epic Pharma Company Information
 Table 86. Epic Pharma Description and Business Overview
 Table 87. Epic Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Epic Pharma Drugs of UDCA and t-UDCA Product
 Table 89. Epic Pharma Recent Developments/Updates
 Table 90. Mitsubishi Tanabe Pharma Company Information
 Table 91. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 92. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product
 Table 94. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 95. Lannett Company Information
 Table 96. Lannett Description and Business Overview
 Table 97. Lannett Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lannett Drugs of UDCA and t-UDCA Product
 Table 99. Lannett Recent Developments/Updates
 Table 100. Viatris Company Information
 Table 101. Viatris Description and Business Overview
 Table 102. Viatris Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Viatris Drugs of UDCA and t-UDCA Product
 Table 104. Viatris Recent Developments/Updates
 Table 105. Bruschettini Company Information
 Table 106. Bruschettini Description and Business Overview
 Table 107. Bruschettini Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bruschettini Drugs of UDCA and t-UDCA Product
 Table 109. Bruschettini Recent Developments/Updates
 Table 110. Impax Company Information
 Table 111. Impax Description and Business Overview
 Table 112. Impax Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Impax Drugs of UDCA and t-UDCA Product
 Table 114. Impax Recent Developments/Updates
 Table 115. Shanghai Pharma Company Information
 Table 116. Shanghai Pharma Description and Business Overview
 Table 117. Shanghai Pharma Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai Pharma Drugs of UDCA and t-UDCA Product
 Table 119. Shanghai Pharma Recent Developments/Updates
 Table 120. Grindeks Company Information
 Table 121. Grindeks Description and Business Overview
 Table 122. Grindeks Drugs of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Grindeks Drugs of UDCA and t-UDCA Product
 Table 124. Grindeks Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Drugs of UDCA and t-UDCA Distributors List
 Table 128. Drugs of UDCA and t-UDCA Customers List
 Table 129. Drugs of UDCA and t-UDCA Market Trends
 Table 130. Drugs of UDCA and t-UDCA Market Drivers
 Table 131. Drugs of UDCA and t-UDCA Market Challenges
 Table 132. Drugs of UDCA and t-UDCA Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drugs of UDCA and t-UDCA
 Figure 2. Global Drugs of UDCA and t-UDCA Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drugs of UDCA and t-UDCA Market Share by Type: 2024 & 2031
 Figure 4. t-UDCA Product Picture
 Figure 5. UDCA Product Picture
 Figure 6. Global Drugs of UDCA and t-UDCA Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drugs of UDCA and t-UDCA Market Share by Application: 2024 & 2031
 Figure 8. Gallstone
 Figure 9. Hepatopathy
 Figure 10. Biliary Disease
 Figure 11. Other
 Figure 12. Global Drugs of UDCA and t-UDCA Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Drugs of UDCA and t-UDCA Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Drugs of UDCA and t-UDCA Sales (2020-2031) & (K Units)
 Figure 15. Global Drugs of UDCA and t-UDCA Average Price (US$/Unit) & (2020-2031)
 Figure 16. Drugs of UDCA and t-UDCA Report Years Considered
 Figure 17. Drugs of UDCA and t-UDCA Sales Share by Manufacturers in 2024
 Figure 18. Global Drugs of UDCA and t-UDCA Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Drugs of UDCA and t-UDCA Players: Market Share by Revenue in Drugs of UDCA and t-UDCA in 2024
 Figure 20. Drugs of UDCA and t-UDCA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Drugs of UDCA and t-UDCA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Drugs of UDCA and t-UDCA Sales Market Share by Country (2020-2031)
 Figure 23. North America Drugs of UDCA and t-UDCA Revenue Market Share by Country (2020-2031)
 Figure 24. United States Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Drugs of UDCA and t-UDCA Sales Market Share by Country (2020-2031)
 Figure 27. Europe Drugs of UDCA and t-UDCA Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Drugs of UDCA and t-UDCA Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Drugs of UDCA and t-UDCA Revenue Market Share by Region (2020-2031)
 Figure 35. China Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Drugs of UDCA and t-UDCA Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Drugs of UDCA and t-UDCA Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Drugs of UDCA and t-UDCA Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Drugs of UDCA and t-UDCA Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Drugs of UDCA and t-UDCA Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Drugs of UDCA and t-UDCA by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Drugs of UDCA and t-UDCA by Type (2020-2031)
 Figure 56. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Drugs of UDCA and t-UDCA by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Drugs of UDCA and t-UDCA by Application (2020-2031)
 Figure 59. Global Drugs of UDCA and t-UDCA Price (US$/Unit) by Application (2020-2031)
 Figure 60. Drugs of UDCA and t-UDCA Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart